Recent reports have shown that the MEK5/ERK5 pathway is implicated in the regulation of cell proliferation, and that increased MEK5/ERK5 signalling results in increased cell proliferation, invasion and metastatic spread during prostate carcinogenesis (Kato et al, 1998; Mehta et al, 2003). This evidence concerns the gene MAP2K5 and prostatitis.